Cystic Fibrosis DNA Screen

single page view

General Information

Lab Name
Cystic Fibrosis DNA Screen
Lab Code
CFDNA
Epic Ordering
Cystic Fibrosis DNA Screen
Description

Cystic fibrosis (CF) is an autosomal recessive disease caused by pathogenic variants in the CFTR gene (cystic fibrosis transmembrane conductance regulator). This assay detects over 400 disease-causing variants in CFTR, and includes virtually all pathogenic or likely pathogenic variants present in the CFTR2 Database. (http://cftr2.org and Grody et al. 2001)

CFTR Intron 8 Poly(T) test is reported for individuals with the NM_000492.3:c.350G>A, p.R117H variant AND for evaluating CBAVD.

Indications for Testing Include

  • Carrier testing in an individual with or without family history of CF, or in the spouse of a CF carrier
  • Evaluate suspected CF
  • Establish mutation status of CF-affected individual or obligate carrier
  • Evaluate male infertility due to Congenital Bilateral Absence of Vas Deferens
  • Follow up prenatal ultrasound findings that are suspicious for CF
  • Evaluate idiopathic chronic pancreatitis
References

Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstet Gynecol 2017 Mar;129(3):e41-e55.

Deignan JL, et al. CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2020 Aug;22(8):1288-1295.

Grody WW, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001, 3:149-54. 11280952

Ong T, Marshall SG, Karczeski BA, et al. Cystic Fibrosis and Congenital Absence of the Vas Deferens. 2001 Mar 26 [Updated 2017 Feb 2]. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1250/

Forms & Requisitions

Genetics Requisition

Synonyms
5T Allele, CBAVD, CF Mutation DNA, CFTR Mutation, Congenital Bilateral Absence of the Vas Deferens, Delta F508, DNA-CF Gene Study, Intron 8, Poly(T)
Components

Interpretation

Method

Test performed by targeted capture for CFTR followed by next-generation sequencing with Illumina technology. Sequences are aligned to the human genome reference (hg19). This assay sequences all exons and flanking intronic sequences of CFTR to detect single nucleotide variants, and small insertions and deletions. Large insertions and deletions are not detectable by this assay. Reporting is limited to pathogenic and likely pathogenic variants (i.e., variants of uncertain significance will not be reported). CFDNA May 2022-CFDNA reportable variants

This test was developed and its performance characteristics determined by the University of Washington Department of Laboratory Medicine and Pathology. It has not been cleared or approved by the US Food and Drug Administration. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.

Reference Range
See individual components
Ref. Range Notes

No pathogenic or likely pathogenic variant detected.

Interferences and Limitations

CFDNA is not a full sequencing test. If there is a high index of suspicion for cystic fibrosis, consider ordering full CFTR gene sequencing.

References

Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstet Gynecol 2017 Mar;129(3):e41-e55.

Deignan JL, et al. CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2020 Aug;22(8):1288-1295.

Grody WW, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001, 3:149-54. 11280952

Ong T, Marshall SG, Karczeski BA, et al. Cystic Fibrosis and Congenital Absence of the Vas Deferens. 2001 Mar 26 [Updated 2017 Feb 2]. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1250/

Guidelines

Ordering & Collection

Specimen Type
Blood, saliva, amniocytes, chorionic villus tissue or cultured cells
Collection

BLOOD:

  • Adult: 5 mL LAVENDER TOP tube
  • Child: 2 mL LAVENDER TOP tube
  • Also acceptable: YELLOW TOP (ACD) tube
  • Unacceptable: Heparin green top tubes

AMNIOCYTES or CULTURED CHORIONIC VILLUS CELLS:

  • Two (2) T23 or One (1) T75 flask (minimum 1-T25 flask)

CHORIONIC VILLIS and/or TISSUE:

  • In sterile tube or culture media, at least 5 mg tissue.

Prenatal testing requires concomitant testing for maternal cell contamination (see Online Test Guide, Lab Mnemonic Maternal Cell Contamination [MCC] for ordering and specimen requirements)

Forms & Requisitions

Genetics Requisition

Handling Instructions

Blood: Refrigerate whole blood up to 1 week.

Amniocytes & cultured CVS cells: hold flasks at room temperature.

Chorionic villi &/or tissue: hold at room temperature

Saliva:
Contact laboratory for validated collection kit.

Outside Laboratories: Ship whole blood at ambient temperature for receipt within 1 week of specimen collection.- For cultured amniocytes or chorionic villus cells and for CVS or other tissue, transport and store at room temperature within 24 hours of obtaining CV or removing cultured cells from incubator.

Quantity
requested: Entire specimen
minimum: Blood: 1 mL. Amniocytes, cultured chorionic villus cells, chorionic villi or tissue: as above.

Processing

Processing

Processing: Please notify genetics about amniocytes, cultured chorionic villus cells, chorionic villi or tissue.

Note: CF Mutation Analysis is to be done in-house UNLESS approved by Genetics to be sent to a referral lab. If this testing is for diagnosis of Congenital Bilateral Absence of the Vas Deferens (CBAVD), please note this in a comment when logging in the specimen. (The genetics lab will report additional information in these cases.).

Performance

LIS Dept Code
Genetics (GEN)
Performing Location(s)
UW-MT Genetics

Attention: Genetics Lab
Clinical lab, Room NW220
University of Washington Medical Center
1959 NE Pacific Street
Seattle, WA 98195

Tel: 206-598–6429 M–F (7:30 AM–4:00 PM)
Fax: 206-598–0304
Lab email: cgateam@uw.edu

Tel (EXOME only): 206-543-0459

Manager
Joe Bernal

Genetic Counselors
Angela Jacobson, MS, LGC
Sandra Coe, MS,LGC
Dru Leistritz, MS, LGC(EXOME testing only)

Variant Review Scientist
Ankita Jhuraney, PhD
Sarah Paolucci, MA, MS, LGC
Catherine A. Darcey, MSc
Daniel W. Serber, PhD, MS, LCGC

Faculty
Jillian Buchan, PhD, FACMG
Runjun Kumar, MD, PhD
Christina Lockwood, PhD, DABCC, DABMGG
Brian Shirts, MD, PhD
Abbye McEwen, MD, PhD
Colin Pritchard, MD, PhD
Vera Paulson, MD, PhD
Eric Konnick, MD, MS
He Fang, PhD

Frequency
Performed weekly. Results within 2 weeks.
Available STAT?
No

Billing & Coding

CPT codes
81220
Billing Comments

For pricing information, contact Client Support Services 206-520-4600 or 800-713-5198.

LOINC
21656-4
Interfaced Order Code
UOW167